INVENT MEDIC SWEDEN AB Financials Invent Medic Sweden AB
Equities
IMS
SE0007603402
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.82 SEK | +0.74% |
|
-.--% | +36.67% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 229.2 | 152.1 | 116.5 | 101.9 | 32.71 | 25.66 |
| Enterprise Value (EV) 1 | 223.1 | 139.2 | 115.4 | 93.7 | 18.92 | 24.99 |
| P/E ratio | -28.1 x | -15.7 x | -9.19 x | -6.19 x | -1.72 x | -2.14 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 271 x | 313 x | 188 x | 67.2 x | 17.4 x | 8.26 x |
| EV / Revenue | 263 x | 287 x | 186 x | 61.8 x | 10 x | 8.05 x |
| EV / EBITDA | -27.5 x | -15 x | -9.12 x | -6.17 x | -1.01 x | -2.15 x |
| EV / FCF | -44.4 x | -19.7 x | -16.5 x | -8.87 x | -1.62 x | -2.87 x |
| FCF Yield | -2.25% | -5.08% | -6.07% | -11.3% | -61.6% | -34.8% |
| Price to Book | 28.6 x | 9.24 x | 31.4 x | 8.46 x | 1.88 x | 4.77 x |
| Nbr of stocks (in thousands) | 9,023 | 10,311 | 10,311 | 14,731 | 25,759 | 25,759 |
| Reference price 2 | 25.40 | 14.75 | 11.30 | 6.920 | 1.270 | 0.9960 |
| Announcement Date | 4/13/18 | 4/12/19 | 4/14/20 | 4/13/21 | 4/14/22 | 4/14/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.8469 | 0.4854 | 0.6203 | 1.517 | 1.884 | 3.106 |
| EBITDA 1 | -8.117 | -9.267 | -12.65 | -15.19 | -18.66 | -11.62 |
| EBIT 1 | -8.149 | -9.31 | -12.74 | -15.4 | -18.86 | -11.94 |
| Operating Margin | -962.14% | -1,917.88% | -2,053.48% | -1,015.06% | -1,000.92% | -384.47% |
| Earnings before Tax (EBT) 1 | -8.148 | -9.311 | -12.74 | -15.64 | -19.03 | -11.98 |
| Net income 1 | -8.148 | -9.311 | -12.74 | -15.64 | -19.03 | -11.98 |
| Net margin | -962.09% | -1,918.12% | -2,054.4% | -1,031.31% | -1,009.91% | -385.67% |
| EPS 2 | -0.9031 | -0.9400 | -1.230 | -1.118 | -0.7387 | -0.4650 |
| Free Cash Flow 1 | -5.026 | -7.068 | -7.005 | -10.56 | -11.65 | -8.7 |
| FCF margin | -593.39% | -1,456.11% | -1,129.26% | -696.23% | -618.55% | -280.12% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/13/18 | 4/12/19 | 4/14/20 | 4/13/21 | 4/14/22 | 4/14/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 6.03 | 12.9 | 1.11 | 8.23 | 13.8 | 0.67 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -5.03 | -7.07 | -7 | -10.6 | -11.7 | -8.7 |
| ROE (net income / shareholders' equity) | -109% | -76.1% | -126% | -198% | -129% | -105% |
| ROA (Net income/ Total Assets) | -58.7% | -42.6% | -62.6% | -79.2% | -61.1% | -47.8% |
| Assets 1 | 13.87 | 21.85 | 20.36 | 19.75 | 31.13 | 25.07 |
| Book Value Per Share 2 | 0.8900 | 1.600 | 0.3600 | 0.8200 | 0.6700 | 0.2100 |
| Cash Flow per Share 2 | 0.6700 | 1.250 | 0.2500 | 0.7400 | 0.6100 | 0.1200 |
| Capex | - | 0.43 | - | - | 0.21 | 0.01 |
| Capex / Sales | - | 88.38% | - | - | 11.25% | 0.23% |
| Announcement Date | 4/13/18 | 4/12/19 | 4/14/20 | 4/13/21 | 4/14/22 | 4/14/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +36.67% | 3.04M | |
| +8.29% | 124B | |
| -5.61% | 11.02B | |
| +4.83% | 8.88B | |
| +39.60% | 5.45B | |
| -22.04% | 4.74B | |
| +8.39% | 3.44B | |
| -6.28% | 2.84B | |
| -10.23% | 2.15B | |
| -5.99% | 2.11B |
- Stock Market
- Equities
- IMS Stock
- Financials Invent Medic Sweden AB